Literature DB >> 27188659

Menopause.

Susan R Davis1, Irene Lambrinoudaki2, Maryann Lumsden3, Gita D Mishra4, Lubna Pal5, Margaret Rees6, Nanette Santoro7, Tommaso Simoncini8.   

Abstract

Menopause is an inevitable component of ageing and encompasses the loss of ovarian reproductive function, either occurring spontaneously or secondary to other conditions. It is not yet possible to accurately predict the onset of menopause, especially early menopause, to give women improved control of their fertility. The decline in ovarian oestrogen production at menopause can cause physical symptoms that may be debilitating, including hot flushes and night sweats, urogenital atrophy, sexual dysfunction, mood changes, bone loss, and metabolic changes that predispose to cardiovascular disease and diabetes. The individual experience of the menopause transition varies widely. Important influential factors include the age at which menopause occurs, personal health and wellbeing, and each woman's environment and culture. Management options range from lifestyle assessment and intervention through to hormonal and non-hormonal pharmacotherapy, each of which has specific benefits and risks. Decisions about therapy for perimenopausal and postmenopausal women depend on symptomatology, health status, immediate and long-term health risks, personal life expectations, and the availability and cost of therapies. More effective and safe therapies for the management of menopausal symptoms need to be developed, particularly for women who have absolute contraindications to hormone therapy. For an illustrated summary of this Primer, visit: http://go.nature.com/BjvJVX.

Entities:  

Mesh:

Year:  2015        PMID: 27188659     DOI: 10.1038/nrdp.2015.4

Source DB:  PubMed          Journal:  Nat Rev Dis Primers        ISSN: 2056-676X            Impact factor:   52.329


  61 in total

1.  Effects of estrogen-like plant compounds on the vaginal epithelium pituitary, adrenal glands, and uterus of rats.

Authors:  Gismar Mc Rodrigues; Bruno Db Borges; Leticia Gabriela Q Moreira; Érica Aparecida G Rossete; Suzelei de Castro Franca
Journal:  Exp Biol Med (Maywood)       Date:  2018-12-03

2.  Neuroendocrine aging precedes perimenopause and is regulated by DNA methylation.

Authors:  Eliza R Bacon; Aarti Mishra; Yiwei Wang; Maunil K Desai; Fei Yin; Roberta Diaz Brinton
Journal:  Neurobiol Aging       Date:  2018-10-05       Impact factor: 4.673

3.  Genomic analysis identifies variants that can predict the timing of menopause.

Authors:  Krina T Zondervan
Journal:  Nature       Date:  2021-08-04       Impact factor: 49.962

Review 4.  Symptoms of menopause - global prevalence, physiology and implications.

Authors:  Patrizia Monteleone; Giulia Mascagni; Andrea Giannini; Andrea R Genazzani; Tommaso Simoncini
Journal:  Nat Rev Endocrinol       Date:  2018-02-02       Impact factor: 43.330

Review 5.  Addressing the Role of Obesity in Endometrial Cancer Risk, Prevention, and Treatment.

Authors:  Michaela A Onstad; Rosemarie E Schmandt; Karen H Lu
Journal:  J Clin Oncol       Date:  2016-11-07       Impact factor: 44.544

6.  Does menopausal transition really influence mental health? Findings from the prospective long-term Zurich study.

Authors:  Wulf Rössler; Vladeta Ajdacic-Gross; Anita Riecher-Rössler; Jules Angst; Michael P Hengartner
Journal:  World Psychiatry       Date:  2016-06       Impact factor: 49.548

7.  Association between age at menopause and fracture risk: a systematic review and meta-analysis.

Authors:  Panagiotis Anagnostis; Pavlos Siolos; Nifon K Gkekas; Nikoletta Kosmidou; Aikaterini-Maria Artzouchaltzi; Konstantinos Christou; Stavroula A Paschou; Michael Potoupnis; Eustathios Kenanidis; Eleftherios Tsiridis; Irene Lambrinoudaki; John C Stevenson; Dimitrios G Goulis
Journal:  Endocrine       Date:  2018-09-10       Impact factor: 3.633

8.  Influence of the estrus cycle of the mouse on the disposition of SHetA2 after vaginal administration.

Authors:  Sanjida Mahjabeen; Manolya Kukut Hatipoglu; Doris M Benbrook; Stanley D Kosanke; David Garcia-Contreras; Lucila Garcia-Contreras
Journal:  Eur J Pharm Biopharm       Date:  2018-07-04       Impact factor: 5.571

9.  Pharmacokinetics and Pharmacodynamics of Escalating Doses of SHetA2 After Vaginal Administration to Mice.

Authors:  Sanjida Mahjabeen; Manolya Kukut Hatipoglu; Doris M Benbrook; Lucila Garcia-Contreras
Journal:  J Pharm Sci       Date:  2018-09-06       Impact factor: 3.534

Review 10.  Irisin-Associated Neuroprotective and Rehabilitative Strategies for Stroke.

Authors:  Melissa Ann Huberman; Nathan D d'Adesky; Qismat Bahar Niazi; Miguel A Perez-Pinzon; Helen M Bramlett; Ami P Raval
Journal:  Neuromolecular Med       Date:  2021-07-03       Impact factor: 3.843

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.